Stock listing
AFT Stock Price, News, Filings & Events — Aft Pharmaceuticals Ltd.
Selected listing: AFT · NZX · NZD · NZ
This page tracks Aft Pharmaceuticals Ltd.'s AFT:NZX listing on NZX in NZD for NZ, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AFT:NZX. AFT:NZX is the stock-level entry point for investors researching Aft Pharmaceuticals Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aft Pharmaceuticals Ltd. is a public company listed on the New Zealand market under the ticker AFT. The company has a market capitalization of approximately NZD 242.97 million. Aft Pharmaceuticals focuses on developing and commercializing innovative pharmaceutical products.

- Ticker
- AFT:NZX
- Asset type
- Stock
- Market cap
- $274.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NZX
- Currency
- NZD
Aft Pharmaceuticals Ltd. AFT:NZX stock context
This page tracks Aft Pharmaceuticals Ltd.'s AFT:NZX listing on NZX in NZD for NZ, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AFT:NZX. AFT:NZX is the stock-level entry point for investors researching Aft Pharmaceuticals Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aft Pharmaceuticals Ltd. is a public company listed on the New Zealand market under the ticker AFT. The company has a market capitalization of approximately NZD 242.97 million. Aft Pharmaceuticals focuses on developing and commercializing innovative pharmaceutical products.
Latest news from Aft Pharmaceuticals Ltd.
Aft Pharmaceuticals Ltd. earnings calls
AFT Pharmaceuticals Limited (AFP) Q2 2026 Earnings Call
November 19, 2025 · Replay with transcript and chapters
AFT Pharmaceuticals Limited (AFP) Q4 2024 Earnings Call
May 23, 2024 · Replay with transcript and chapters
AFT Pharmaceuticals Limited (AFP) Q2 2024 Earnings Call
November 22, 2023 · Replay with transcript and chapters
AFT Pharmaceuticals Limited (AFP) Q4 2023 Earnings Call
May 21, 2023 · Replay with transcript and chapters
Research Aft Pharmaceuticals Ltd.
Aft Pharmaceuticals Ltd. investor report
Review AI stock analysis and investor report context for AFT:NZX.
Aft Pharmaceuticals Ltd. company profile
View the public company page for Aft Pharmaceuticals Ltd. on 6ix.
Aft Pharmaceuticals Ltd. news
Read company news and market updates connected to Aft Pharmaceuticals Ltd..
Aft Pharmaceuticals Ltd. investor events
Find investor webinars, events, and replay context for Aft Pharmaceuticals Ltd..